Buccal, polar and non-polar spray or capsule containing drugs for treating pain

a technology of polar and non-polar spray or capsules and drugs, which is applied in the direction of amide active ingredients, drug compositions, aerosol delivery, etc., can solve the problems of presenting their own problems, and achieve the effect of rapid absorption through the oral mucosa and fast onset of

Inactive Publication Date: 2009-05-14
DUGGER III HARRY A
View PDF15 Cites 45 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0003]A buccal aerosol spray or soft bite gelatin capsule using a polar or non-polar solvent has now been developed which provides biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect.

Problems solved by technology

However, formulations suitable for such administration by these latter routes present their own problems.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Buccal, polar and non-polar spray or capsule containing drugs for treating pain
  • Buccal, polar and non-polar spray or capsule containing drugs for treating pain

Examples

Experimental program
Comparison scheme
Effect test

example 1

Biologically Active Peptides including Peptide Hormones

[0047]A. Cyclosporine Lingual Spray

most preferredAmountspreferred amountamountcyclosporine5-5010-3515-25water5-207.5-50 9.5-12 ethanol5-607.5-50 10-20polyethylene glycol20-60 30-4535-40flavors0.1-5  1-42-3

[0048]B. Cyclosporine Non-Polar Lingual Spray

most preferredAmountspreferred amountamountcyclosporine 1-50 3-40 5-30Migylol202530-40Polyoxyethylated202530-40castor oilButane25-8030-7033-50flavors0.1-5  1-42-3

[0049]C. Cyclosporine Non-Polar Bite Capsule

most preferredAmountspreferred amountamountcyclosporine 1-35 5-2510-20olive oil25-6035-5530-45polyoxyethylated25-6035-5530-45oleic glyceridesflavors0.1-5  1-42-3

[0050]D. Cyclosporine Bite Capsule

most preferredAmountspreferred amountamountcyclosporine5-5010-3515-25polyethylene glycol20-60 30-4535-40glycerin5-307.5-25 10-20propylene glycol5-307.5-25 10-20flavors0.1-10  1-83-6

[0051]E. Sermorelin (as the Acetate) Lingual Spray

Amountspreferred amountmost preferredsermorelin (as the.01-5...

example 2

[0055]CNS active amines and their salts: including but not limited to tricyclic amines, GABA analogues, thiazides, phenothiazine derivatives, serotonin antagonists and serotonin reuptake inhibitors

[0056]A. Sumatriptan Succinate Lingual Spray

most preferredAmountspreferred amountamountsumatriptan succinate0.5-30    1-2010-15ethanol5-607.5-5010-20propylene glycol5-307.5-2010-15polyethylene glycol0-60 30-4535-40water5-307.5-2010-15flavors0.1-5   1-42-3

[0057]B. Sumatriptan Succinate Bite Capsule

most preferredAmountspreferred amountamountsumatriptan succinate0.01-5  0.05-3.5 0.075-1.75 polyethylene glycol25-7030-6035-50glycerin25-7030-6035-50flavors0.1-10 1-83-6

[0058]C. Clozepine Lingual Spray

most preferredAmountspreferred amountamountclozepine0.5-30    1-2010-15ethanol5-607.5-5010-20propylene glycol5-307.5-2010-15polyethylene glycol0-60 30-4535-40water5-307.5-2010-15flavors0.1-5   1-42-3

[0059]D. Clozepine Non-Polar Lingual Spray with Propellant

most preferredAmountspreferred amountamountc...

example 3

Sulfonylureas

[0063]A. Glyburide Lingual Spray

most preferredAmountspreferred amountamountglyburide0.25-25  0.5-200.75-15  ethanol5-60−7.5-50 10-20propylene glycol5-307.5-2010-15polyethylene glycol0-60 30-4535-40water2.5-30    5-20 6-15flavors0.1-5   1-42-3

[0064]B. Glyburide Non-Polar Bite Capsule

most preferredAmountspreferred amountamountglyburide0.01-10  0.025-7.5 0.1-4  olive oil30-6035-5530-50polyoxyethylated30-6035-5530-50oleic glyceridesflavors0.1-5  1-42-3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
pressureaaaaaaaaaa
temperatureaaaaaaaaaa
weightaaaaaaaaaa
Login to view more

Abstract

Buccal aerosol sprays or capsules using polar and non-polar solvent have now been developed which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect. The buccal polar compositions of the invention comprise formulation I: aqueous polar solvent, active compound, and optional flavoring agent; formulation II: aqueous polar solvent, active compound, optionally flavoring agent, and propellant; formulation III: non-polar solvent, active compound, and optional flavoring agent; and formulation IV: non-polar solvent, active compound, optional flavoring agent, and propellant.

Description

CROSS REFERENCE TO RELATED APPLICATIONS[0001]This application is a continuation-in-part of application Ser. No. 09 / 537,118, filed Mar. 29, 2000 which is a continuation-in-part of the U.S. national phase designation of PCT / US97 / 17899 filed Oct. 1, 1997, the disclosures of which are incorporated by reference herein in their entirety.BACKGROUND OF THE INVENTION[0002]It is known that certain biologically active compounds are better absorbed through the oral mucosa than through other routes of administration, such as through the stomach or intestine. However, formulations suitable for such administration by these latter routes present their own problems. For example, the biologically active compound must be compatible with the other components of the composition such as propellants, solvents, etc. Many such formulations have been proposed. For example, U.S. Pat. No. 4,689,233, Dvorsky et al., describes a soft gelatin capsule for the administration of the anti-coronary drug nifedipine dis...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K38/10A61K31/454A61K31/439A61K31/135A61K31/403A61K31/4196A61K31/498A61K31/164A61P29/00A61K31/58A61K31/08A61K31/404A61K31/421A61K38/08A61K31/445A61K38/02A61F13/02A61K9/00A61K9/12A61K9/48A61K31/085A61K31/137A61K31/138A61K31/195A61K31/197A61K31/27A61K31/337A61K31/4178A61K31/433A61K31/4745A61K31/515A61K31/522A61K31/525A61K31/557A61K31/7076A61K38/00A61K38/13A61K38/43A61K39/00A61L9/04A61P31/00A61P33/00A61P35/00
CPCA61K9/0056A61K9/006A61K31/085A61K31/137A61K31/138A61K38/13A61K31/27A61K31/4178A61K31/421A61K31/433A61K31/7076A61K31/197A61P23/02A61P25/04A61P25/06A61P25/36A61P29/00A61P31/00A61P33/00A61P35/00
Inventor DUGGER, III, HARRY A.
Owner DUGGER III HARRY A
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap